Literature DB >> 29430766

Normative data for the Montreal Cognitive Assessment (MoCA) and the Memory Index Score (MoCA-MIS) in Brazil: Adjusting the nonlinear effects of education with fractional polynomials.

Daniel Apolinario1, Marília Funchal Dos Santos2, Eduardo Sassaki2, Fernanda Pegoraro2, Anna Vitoria Alves Pedrini2, Bruna Cestari2, Ana Helena Amaral2, Mayra Mitt2, Marina Bellatti Müller2, Claudia Kimie Suemoto1, Ivan Aprahamian1,2.   

Abstract

OBJECTIVE: To provide age-corrected and education-corrected norms for the Montreal Cognitive Assessment (MoCA) and the Memory Index Score (MoCA-MIS) in Brazil.
METHODS: Community-dwelling outpatients were enrolled if they had no history of neurologic or psychiatric diseases and were not taking any drugs with effects on the central nervous system. Dementia has been excluded with the Functional Activities Questionnaire. The final sample consisted of 597 cognitively healthy Brazilians aged 50 to 90 years. To account for nonlinear relationships, we have used fractional polynomials that provide a flexible parameterization for continuous variables.
RESULTS: According to the original proposed cutoff (≤25 points), 87% of our sample would be considered impaired. Even using a more conservative suggestion (≤22 points), 67% of our normative sample would be regarded as impaired. These data reinforce the need of adjusting cutoffs for schooling in populations with heterogeneous educational backgrounds. MoCA scores presented a nonlinear positive association with education tending to a plateau at higher levels (P < 0.001). On the other hand, MoCA-MIS scores presented a nonlinear negative relationship with age, with an accelerated pattern at higher age levels (P < 0.001).
CONCLUSIONS: We presented normative data for the MoCA and the MoCA-MIS that will facilitate the use of the test in Brazil and, potentially, in other populations with substantial proportions of low-educated individuals. Moreover, we described a systematic approach for adjusting the effects of age and education using fractional polynomials and provided suggestions on how to account for the nonlinear relationship that is frequently encountered between demographic factors and measures of cognitive performance.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognitive function; dementia; mild cognitive impairment; neuropsychological tests; normative study; reference values

Mesh:

Year:  2018        PMID: 29430766     DOI: 10.1002/gps.4866

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  4 in total

1.  Pain and the Montreal Cognitive Assessment (MoCA) in Aging.

Authors:  Josue Cardoso; Brandon Apagueno; Paige Lysne; Lorraine Hoyos; Eric Porges; Joseph L Riley; Roger B Fillingim; Adam J Woods; Ronald Cohen; Yenisel Cruz-Almeida
Journal:  Pain Med       Date:  2021-08-06       Impact factor: 3.750

2.  Influence of Social and Demographic Factors on the Montreal Cognitive Assessment (MoCA) Test in Rural Population of North-Eastern Greece.

Authors:  Anna Tsiakiri; Konstantinos Vadikolias; Grigorios Tripsianis; Pinelopi Vlotinou; Aspasia Serdari; Aikaterini Terzoudi; Ioannis Heliopoulos
Journal:  Geriatrics (Basel)       Date:  2021-04-17

3.  Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly.

Authors:  Cecilia M Serrano; Marcos Sorbara; Alexander Minond; John B Finlay; Raul L Arizaga; Monica Iturry; Patricia Martinez; Gabriela Heinemann; Celina Gagliardi; Andrea Serra; Florencia Ces Magliano; Darío Yacovino; María Martha Esnaola Y Rojas; Adelaida Susana Ruiz; Héctor Gastón Graviotto
Journal:  Dement Neuropsychol       Date:  2020 Apr-Jun

4.  Regression-Based Normative Data for the Montreal Cognitive Assessment (MoCA) and Its Memory Index Score (MoCA-MIS) for Individuals Aged 18-91.

Authors:  Roy P C Kessels; Nathalie R de Vent; Carolien J W H Bruijnen; Michelle G Jansen; Jos F M de Jonghe; Boukje A G Dijkstra; Joukje M Oosterman
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.